Advances · March 20, 2026 · 7 min · By Quentin Asare
The acne microbiome and what is coming next
Research is reframing acne as an imbalance, not an infection, with new treatments to match.

For decades acne was framed as a simple bacterial overgrowth. Newer research tells a more interesting story: the skin hosts many strains of C. acnes, and acne tracks less with how much bacteria is present than with which strains dominate and how the immune system reacts to them. The condition looks more like an imbalance of the skin microbiome than an infection to be sterilized.
That shift is producing new directions, topical agents that selectively target acne-associated strains while sparing beneficial ones, and a renewed scrutiny of how harsh, over-cleansing routines disrupt the microbiome and make things worse. It also explains why blanket antibiotic use, which clears everything indiscriminately, has fallen out of favor.
Clinics that follow the literature closely are already translating this into gentler, more targeted protocols; leading practices regularly discuss emerging treatment approaches in their clinical writing. For patients, the practical lesson predates the science: protect the barrier, avoid over-stripping, and treat acne as a condition to rebalance rather than a surface to scour.
Related reading: Why your acne came back in your 30s and Acne is not a hygiene problem.